Open Journal Systems

Targeted Graphene Oxide for Integrated Tumor Diagnosis and Treatment

Jinghuan Zhang (Oncology Research Society, China)


Integrin αvβ3 (V3) is a typical tumor marker, which provides a basis for the diagnosis of tumor types and also provides potential target for tumor treatment. The chemical nature of V3 is a transmembrane glycoprotein, which is highly expressed on the surface of a variety of tumor cells, such as human malignant glioma (U87-MG). Therefore, the study used U87-MG cells as the treatment model, using V3 monoclonal antibody (V3MA) as the most targeted ligand, coupled with a novel nano-graphene oxide (NGO) as a photothermal agent. A new type of nanoprobe (NGO-mAb-FITC) was constructed for targeted imaging and photothermal therapy of tumor. The nanoprobe has the active targeting effect of recognizing U87-MG of V3-positive cells, but cannot recognize human breast cancer cells (McF-7) with negative expression of V3. By covalently modifying target ligands with fluorescein isothiocyanate (FITC), nanoprobes (NGO-mAb-FITC) can achieve targeted imaging effects on tumor cells. Meanwhile, the photothermal transformation of GO under 805 nm near-infrared (NIR) light enabled tumor cells to specifically absorb NGO-mAb-FITC nanoprobe and realize hyperthermia, thus inducing thermal damage and cell apoptosis. The results showed that NGO-mAb-FITC could effectively identify V3-positive tumor cells and provide evidence for tumor diagnosis. The high photothermal conversion ability of GO provides a new approach for tumor therapy, and GO is expected to be a potential new targeted photothermal conversion probe for tumor imaging diagnosis and photothermal therapy.


Targeted imaging;Photothermal therapy;Nano-grapheneoxide

Full Text:



Argiris K, Panethymitaki C, Tavassoli M. Naturally occurring, tumor-specific, therapeutic proteins. Exp Biol Med (Maywood), 2011, 236: 524–536

Bleyer A. Cancer of the oral cavity and pharynx in young females: Increasing incidence, role of human papilloma virus, and lack of sur- vival improvement. Semin Oncol, 2009, 36: 451–459

Okura H. Usefulness of tumor marker in early diagnosis. Nihon Naika Gakkai Zasshi, 2005, 94: 2479–2485

.Xiang L, Yuan Y, Xing D, et al. Photoacoustic molecular imaging with antibody-functionalized single-walled carbon nanotubes for early diagnosis of tumor. J Biomed Opt, 2009, 14: 021008

Hwang D W, Ko H Y, Lee J H, et al. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an ap- tamer. J Nucl Med, 2010, 51: 98–105

Kim C, Favazza C, Wang L V. In vivo photoacoustic tomography of chemicals: High-resolution functional and molecular optical imaging at new depths. Chem Rev, 2011, 110: 2756–2782

Lamerz R. Role of tumour markers, cytogenetics. Ann Oncol, 1999, 10(Suppl 4): 145–149

Amayo A A, Kuria J G. Clinical application of tumour markers: A review. East Afr Med J, 2009, 86: S76–S83

Berlin J M, Pham T T, Sano D, et al. Noncovalent functionalization of carbon nanovectors with an antibody enables targeted drug delivery.ACS Nano, 2011, 5: 6643–6650

Sun X, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res, 2008, 1: 203–212

Cho H S, Dong Z, Pauletti G M, et al. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: A multifunc-tional nanocarrier system for cancer diagnosis and treatment. ACS Nano, 2010, 4: 5398–5404

Chen J, Chen S, Zhao X, et al. Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug de-livery. J Am Chem Soc, 2008, 130: 16778–16785

De la Zerda A, Liu Z, Bodapati S, et al. Ultrahigh sensitivity carbon nanotube agents for photoacoustic molecular imaging in living mice.Nano Lett, 2010, 10: 2168–2172

Kim J W, Galanzha E I, Shashkov E V, et al. Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast mo-lecular agents. Nat Nanotech, 2009, 4: 688–694

Yang K, Zhang S, Zhang G, et al. Graphene in mice: Ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett, 2010,10: 3318–3323

Kalkanidis M, Pietersz G A, Xiang S D, et al. Methods for nano-particle based vaccine formulation and evaluation of their immunogenic-ity. Methods, 2006, 40: 20–29

Dresselhaus M S, Araujo P T. Perspectives on the 2010 Nobel Prize in physics for graphene. ACS Nano, 2010, 4: 6297–6302

Wang Y, Jaiswal M, Lin M, et al. Electronic properties of nanodiamond decorated graphene. ACS Nano, 2012, 6: 1018–1025

Markovic Z M, Harhaji-Trajkovic L M, Todorovic-Markovic B M, et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials, 2011, 32: 1121–1129

Englert J M, Dotzer C, Yang G, et al. Covalent bulk functionalization of graphene. Nat Chem, 2011, 3: 279–286

Buonaguro L, Petrizzo A, Tornesello M L, et al. Translating tumor antigens into cancer vaccines. Clin Vaccine Immunol, 2011, 18: 23–34

Wang L, Zhao J, Sun Y Y, et al. Characteristics of Raman spectra for graphene oxide from ab initio simulations. J Chem Phys, 2011, 135:184503

Zharv V P. Photothermal imaging of nanoparticles and cells. IEEE J Select Topic Quant Electron, 2005, 11: 733–751



  • There are currently no refbacks.

Copyright (c) 2020 Jinghuan Zhang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.